Tapewire

Nasdaq · USD

FLNA

FILANA THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
7294
SEC CIK
0001069530
Parsed reports
146

Last 12 months

Inside the activity.

6 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202530
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202630
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 23, 2024 Filed Apr 25, 2024 13:15 UTC Exercise / conversionCommon Stock Warrant · Derivative 117,390 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-013144 · rdgdoc.xml · derivative · entry 3

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 0

Underlying: Common Stock · 176,085 shares

Expires 2024-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.underlying_shares: Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.

Read SEC document
April 23, 2024 Filed Apr 25, 2024 13:15 UTC Exercise / conversionCommon Stock 176,085 $22.00 $3,873,870.00
Disclosure

SEC source: 0001437749-24-013144 · rdgdoc.xml · nonDerivative · entry 1

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 469,562

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.

Read SEC document
April 18, 2024 Filed Apr 22, 2024 13:19 UTC
Kupiec James WilliamChief Medical Officer
Exercise / conversionCommon Stock Warrant · Derivative 1,000 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-012643 · rdgdoc.xml · derivative · entry 3

Kupiec James William · CIK 0001839551 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2024-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.underlying_shares: Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.

Read SEC document
April 18, 2024 Filed Apr 22, 2024 13:19 UTC
Kupiec James WilliamChief Medical Officer
Exercise / conversionCommon Stock 1,500 $22.00 $33,000.00
Disclosure

SEC source: 0001437749-24-012643 · rdgdoc.xml · nonDerivative · entry 1

Kupiec James William · CIK 0001839551 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.

Read SEC document
April 17, 2024 Filed Apr 17, 2024 20:21 UTC
Schoen EricChief Financial Officer
Exercise / conversionCommon Stock Warrant · Derivative 1,000 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-012331 · rdgdoc.xml · derivative · entry 5

Schoen Eric · CIK 0001532303 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,920

Underlying: Common Stock · 1,500 shares

Expires 2024-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.underlying_shares: Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.

Read SEC document
April 17, 2024 Filed Apr 17, 2024 20:21 UTC
Schoen EricChief Financial Officer
Exercise / conversionCommon Stock 1,500 $22.00 $33,000.00
Disclosure

SEC source: 0001437749-24-012331 · rdgdoc.xml · nonDerivative · entry 1

Schoen Eric · CIK 0001532303 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.

Read SEC document
January 03, 2024 Filed Apr 17, 2024 20:21 UTC
Schoen EricChief Financial Officer
GrantCommon Stock Warrant · Derivative 800 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-012331 · rdgdoc.xml · derivative · entry 4

Schoen Eric · CIK 0001532303 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By limited liability corporation

Disclosed balance after: 800

Underlying: Common Stock · 1,200 shares

Expires 2024-05-07

F2 · shares: Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.

Read SEC document
January 03, 2024 Filed Apr 17, 2024 20:21 UTC
Schoen EricChief Financial Officer
GrantCommon Stock Warrant · Derivative 7,920 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-012331 · rdgdoc.xml · derivative · entry 3

Schoen Eric · CIK 0001532303 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,920

Underlying: Common Stock · 11,880 shares

Expires 2024-05-07

F2 · shares: Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.

Read SEC document
January 03, 2024 Filed Apr 22, 2024 13:19 UTC
Kupiec James WilliamChief Medical Officer
GrantCommon Stock Warrant · Derivative 1,000 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-012643 · rdgdoc.xml · derivative · entry 2

Kupiec James William · CIK 0001839551 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,500 shares

Expires 2024-05-07

F1 · shares: Represents warrants that were originally issued on January 3, 2024 as a distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.

Read SEC document
January 03, 2024 Filed Apr 25, 2024 13:15 UTC GrantCommon Stock Warrant · Derivative 117,390 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-013144 · rdgdoc.xml · derivative · entry 2

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 176,085

Underlying: Common Stock · 176,085 shares

Expires 2024-05-07

F1 · shares: Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.

Read SEC document
January 03, 2024 Filed Apr 30, 2024 13:13 UTC GrantCommon Stock Warrant · Derivative 354,740 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-013866 · rdgdoc.xml · derivative · entry 4

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 354,740

Underlying: Common Stock · 532,110 shares

Expires 2024-05-07

F1 · shares: Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.

Read SEC document
January 03, 2024 Filed Apr 30, 2024 13:13 UTC GrantCommon Stock Warrant · Derivative 72,000 $0.00 Strike: $33.00 $0.00
Disclosure

SEC source: 0001437749-24-013866 · rdgdoc.xml · derivative · entry 3

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By family

Disclosed balance after: 72,000

Underlying: Common Stock · 108,000 shares

Expires 2024-05-07

F1 · shares: Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.

Read SEC document
December 06, 2023 Filed Dec 7, 2023 21:57 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $21.71 $0.00
Disclosure

SEC source: 0001437749-23-033892 · rdgdoc.xml · derivative · entry 1

Gravier Pierre · CIK 0001984065 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-06

F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
December 06, 2023 Filed Dec 7, 2023 21:55 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $21.71 $0.00
Disclosure

SEC source: 0001437749-23-033890 · rdgdoc.xml · derivative · entry 1

Anderson Robert Eugene Jr · CIK 0002001911 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-06

F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 22:06 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $21.71 $0.00
Disclosure

SEC source: 0001437749-23-034025 · rdgdoc.xml · derivative · entry 1

Nicaise Claude · CIK 0001644162 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-12-06

F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
October 03, 2023 Filed Oct 4, 2023 22:36 UTC
Schoen EricChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $17.54 $0.00
Disclosure

SEC source: 0001437749-23-027702 · rdgdoc.xml · derivative · entry 1

Schoen Eric · CIK 0001532303 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-10-03

F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
October 03, 2023 Filed Oct 4, 2023 22:33 UTC
Cook Robert ChristopherSVP & General Counsel
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $17.54 $0.00
Disclosure

SEC source: 0001437749-23-027700 · rdgdoc.xml · derivative · entry 1

Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2033-10-03

F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
October 03, 2023 Filed Oct 4, 2023 22:29 UTC
Kupiec James WilliamChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $17.54 $0.00
Disclosure

SEC source: 0001437749-23-027698 · rdgdoc.xml · derivative · entry 1

Kupiec James William · CIK 0001839551 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-10-03

F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
October 03, 2023 Filed Oct 4, 2023 22:24 UTC
BARBIER REMIDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $17.54 $0.00
Disclosure

SEC source: 0001437749-23-027696 · rdgdoc.xml · derivative · entry 2

BARBIER REMI · CIK 0001133806 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-10-03

F2 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
October 03, 2023 Filed Oct 4, 2023 22:24 UTC
BARBIER REMIDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 300,000 $0.00 Strike: $17.54 $0.00
Disclosure

SEC source: 0001437749-23-027696 · rdgdoc.xml · derivative · entry 1

BARBIER REMI · CIK 0001133806 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2033-10-03

F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month.

Read SEC document
August 23, 2023 Filed Aug 24, 2023 20:06 UTC PurchaseCommon Stock 30,000 $17.45 $523,500.00
Disclosure

SEC source: 0001069530-23-000045 · certent-form4.xml · nonDerivative · entry 1

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 886,851

F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $17.21 to $17.64 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.

Read SEC document
August 22, 2023 Filed Aug 23, 2023 20:58 UTC PurchaseCommon Stock 16,571 $16.65 $275,907.15
Disclosure

SEC source: 0001069530-23-000043 · certent-form4.xml · nonDerivative · entry 2

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 293,477

F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $16.57 to $16.70 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:58 UTC PurchaseCommon Stock 1,906 $16.80 $32,020.80
Disclosure

SEC source: 0001069530-23-000043 · certent-form4.xml · nonDerivative · entry 1

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 276,906

Read SEC document
June 12, 2023 Filed Jun 12, 2023 20:53 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.95 Strike: $0.95 $950.00
Disclosure

SEC source: 0001069530-23-000037 · certent-form4.xml · derivative · entry 2

SCANNON PATRICK J MD PHD · CIK 0001222790 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 1,000 shares

Expires 2028-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2023 Filed Jun 12, 2023 20:53 UTC Exercise / conversionCommon Stock 1,000 $0.95 $950.00
Disclosure

SEC source: 0001069530-23-000037 · certent-form4.xml · nonDerivative · entry 1

SCANNON PATRICK J MD PHD · CIK 0001222790 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:11 UTC
BARBIER REMIDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 71,428 $16.87 Strike: $16.87 $1,204,990.36
Disclosure

SEC source: 0001069530-23-000035 · certent-form4.xml · derivative · entry 6

BARBIER REMI · CIK 0001133806 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 71,428 shares

Expires 2023-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:11 UTC
BARBIER REMIDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,285 $16.87 Strike: $16.87 $240,987.95
Disclosure

SEC source: 0001069530-23-000035 · certent-form4.xml · derivative · entry 5

BARBIER REMI · CIK 0001133806 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family

Disclosed balance after: 0

Underlying: Common Stock · 14,285 shares

Expires 2023-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:11 UTC
BARBIER REMIDirector · President and CEO
Tax withholdingCommon Stock 47,723 $25.25 $1,205,005.75
Disclosure

SEC source: 0001069530-23-000035 · certent-form4.xml · nonDerivative · entry 4

BARBIER REMI · CIK 0001133806 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 734,279

F1 · shares: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:11 UTC
BARBIER REMIDirector · President and CEO
Exercise / conversionCommon Stock 71,428 $16.87 $1,204,990.36
Disclosure

SEC source: 0001069530-23-000035 · certent-form4.xml · nonDerivative · entry 3

BARBIER REMI · CIK 0001133806 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 782,002

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:11 UTC
BARBIER REMIDirector · President and CEO
Tax withholdingCommon Stock 9,545 $25.25 $241,011.25
Disclosure

SEC source: 0001069530-23-000035 · certent-form4.xml · nonDerivative · entry 2

BARBIER REMI · CIK 0001133806 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family

Disclosed balance after: 380,852

F1 · shares: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:11 UTC
BARBIER REMIDirector · President and CEO
Exercise / conversionCommon Stock 14,285 $16.87 $240,987.95
Disclosure

SEC source: 0001069530-23-000035 · certent-form4.xml · nonDerivative · entry 1

BARBIER REMI · CIK 0001133806 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family

Disclosed balance after: 390,397

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:08 UTC Exercise / conversionStock Opton (Right to Buy) · Derivative 2,142 $16.66 Strike: $16.66 $35,685.72
Disclosure

SEC source: 0001069530-23-000033 · certent-form4.xml · derivative · entry 7

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,142 shares

Expires 2023-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:08 UTC Exercise / conversionStock Opton (Right to Buy) · Derivative 3,571 $16.66 Strike: $16.66 $59,492.86
Disclosure

SEC source: 0001069530-23-000033 · certent-form4.xml · derivative · entry 6

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,571 shares

Expires 2023-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:08 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,571 $19.60 Strike: $19.60 $69,991.60
Disclosure

SEC source: 0001069530-23-000033 · certent-form4.xml · derivative · entry 5

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,571 shares

Expires 2023-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:08 UTC Exercise / conversionCommon Stock 2,142 $16.66 $35,685.72
Disclosure

SEC source: 0001069530-23-000033 · certent-form4.xml · nonDerivative · entry 3

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 856,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:08 UTC Exercise / conversionCommon Stock 3,571 $16.66 $59,492.86
Disclosure

SEC source: 0001069530-23-000033 · certent-form4.xml · nonDerivative · entry 2

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 854,709

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:08 UTC Exercise / conversionCommon Stock 3,571 $19.60 $69,991.60
Disclosure

SEC source: 0001069530-23-000033 · certent-form4.xml · nonDerivative · entry 1

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 851,138

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:14 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $22.34 Strike: $22.34 $446,800.00
Disclosure

SEC source: 0001069530-23-000031 · certent-form4.xml · derivative · entry 1

SCANNON PATRICK J MD PHD · CIK 0001222790 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-05-04

F1 · derivative.exercise_date: Stock options vest over a three (3) year period at a rate of 1/36th per month.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:13 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $22.34 Strike: $22.34 $111,700.00
Disclosure

SEC source: 0001069530-23-000029 · certent-form4.xml · derivative · entry 2

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-05-04

F2 · derivative.exercise_date: Stock options vest over a one (1) year period at a rate of 1/12th per month.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:13 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $22.34 Strike: $22.34 $446,800.00
Disclosure

SEC source: 0001069530-23-000029 · certent-form4.xml · derivative · entry 1

ROBERTSON SANFORD · CIK 0001250105 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 20,000 shares

Expires 2033-05-04

F1 · derivative.exercise_date: Stock options vest over a three (3) year period at a rate of 1/36th per month.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:10 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $22.34 Strike: $22.34 $446,800.00
Disclosure

SEC source: 0001069530-23-000027 · certent-form4.xml · derivative · entry 1

O DONNELL MICHAEL J · CIK 0001245266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-05-04

F1 · derivative.exercise_date: Stock options vest over a three (3) year period at a rate of 1/36th per month.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:08 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $22.34 Strike: $22.34 $111,700.00
Disclosure

SEC source: 0001069530-23-000025 · certent-form4.xml · derivative · entry 2

GUSSIN ROBERT Z · CIK 0001245263 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-05-04

F2 · derivative.exercise_date: Stock options vest over a one (1) year period at a rate of 1/12th per month.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:08 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $22.34 Strike: $22.34 $446,800.00
Disclosure

SEC source: 0001069530-23-000025 · certent-form4.xml · derivative · entry 1

GUSSIN ROBERT Z · CIK 0001245263 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 20,000 shares

Expires 2033-05-04

F1 · derivative.exercise_date: Stock options vest over a three (3) year period at a rate of 1/36th per month.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:06 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $22.34 Strike: $22.34 $111,700.00
Disclosure

SEC source: 0001069530-23-000023 · certent-form4.xml · derivative · entry 2

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-05-04

F2 · derivative.exercise_date: Stock options vest over a one (1) year period at a rate of 1/12th per month.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:06 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $22.34 Strike: $22.34 $446,800.00
Disclosure

SEC source: 0001069530-23-000023 · certent-form4.xml · derivative · entry 1

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 20,000 shares

Expires 2033-05-04

F1 · derivative.exercise_date: Stock options vest over a three (3) year period at a rate of 1/36th per month.

Read SEC document
May 01, 2023 Filed May 2, 2023 20:04 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,571 $19.60 Strike: $19.60 $69,991.60
Disclosure

SEC source: 0001069530-23-000019 · certent-form4.xml · derivative · entry 7

GUSSIN ROBERT Z · CIK 0001245263 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,571 shares

Expires 2023-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2023 Filed May 2, 2023 20:04 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,571 $16.66 Strike: $16.66 $59,492.86
Disclosure

SEC source: 0001069530-23-000019 · certent-form4.xml · derivative · entry 6

GUSSIN ROBERT Z · CIK 0001245263 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,571 shares

Expires 2023-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2023 Filed May 2, 2023 20:04 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,142 $16.66 Strike: $16.66 $35,685.72
Disclosure

SEC source: 0001069530-23-000019 · certent-form4.xml · derivative · entry 5

GUSSIN ROBERT Z · CIK 0001245263 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,142 shares

Expires 2023-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2023 Filed May 2, 2023 20:04 UTC Tax withholdingCommon Stock 7,077 $23.34 $165,177.18
Disclosure

SEC source: 0001069530-23-000019 · certent-form4.xml · nonDerivative · entry 4

GUSSIN ROBERT Z · CIK 0001245263 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,617

F1 · shares: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.

Read SEC document
May 01, 2023 Filed May 2, 2023 20:04 UTC Exercise / conversionCommon Stock 3,571 $19.60 $69,991.60
Disclosure

SEC source: 0001069530-23-000019 · certent-form4.xml · nonDerivative · entry 3

GUSSIN ROBERT Z · CIK 0001245263 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.